Displaying items by tag: department of neurology

Reintegration into school has been a noticeably neglected area of focus in concussion research, particularly in comparison to research on return-to-play. When and how a student should be fully integrated into the classroom are just two questions UAB and Children’s of Alabama researchers are looking to answer.
UAB’s long-running study of cannabidiol reveals potential interactions between CBD and some commonly used anti-epileptic drugs.
A UAB pain specialist says the opioid epidemic will lead to profound changes in legitimate opioid use for pain management-
Leading neuroscientist Ron Lazar joins UAB as director of the McKnight Brain Institute, a multidisciplinary research enterprise on learning and memory in aging.
At a time when medical cannabis and cannabis-based products are gaining traction in the treatment of seizures, one of UAB’s CBD oil investigators serves as a guest editor for a special research journal devoted to cannabinoid research.
A committee selected by the Michael J. Fox Foundation for Parkinson’s Research awarded UAB and four other centers as Edmond J. Safra Fellowship in Movement Disorders sites-
Advances in brain imaging allowing early detection of the plaques implicated in Alzheimer’s disease have pushed prevention strategies in the fight against dementia.
UAB’s School of Medicine will host The Alzheimer’s Foundation of America’s National Educating America Tour at UAB to discuss best practices for caregiving, current research efforts and resources for lives affected by Alzheimer’s.
UAB is a clinical site for the A4 Study of Alzheimer’s disease, recently featured in Newsweek magazine.
The National Multiple Sclerosis Society has named UAB a Center of Comprehensive MS Care, the highest designation in its three-tiered system.

New research from UAB sheds light on the connection between Parkinson’s disease and the trillions of bacteria in our guts. 

A seven-year effort led by a UAB neurologist has established the first guidelines for the use of fMRI in epilepsy surgery.
UAB will study a drug originally developed for Parkinson’s disease that may help reduce breath holding in patients with Rett syndrome.
Page 8 of 14